|
DEPDC1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.53147999999437E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.13039999991716E-07 |
| Normal-vs-Stage2 |
1.810640E-01 |
| Normal-vs-Stage3 |
4.05390000000061E-05 |
| Normal-vs-Stage4 |
2.898400E-01 |
| Stage1-vs-Stage2 |
3.462200E-01 |
| Stage1-vs-Stage3 |
1.079360E-01 |
| Stage1-vs-Stage4 |
1.362910E-03 |
| Stage2-vs-Stage3 |
5.408000E-01 |
| Stage2-vs-Stage4 |
5.046800E-01 |
| Stage3-vs-Stage4 |
1.141840E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.3467999999991E-05 |
| Normal-vs-AfricanAmerican |
4.39029999999008E-06 |
| Normal-vs-Asian |
2.618600E-01 |
| Caucasian-vs-AfricanAmerican |
6.569900E-02 |
| Caucasian-vs-Asian |
8.027400E-01 |
| AfricanAmerican-vs-Asian |
2.961200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.21160000000365E-05 |
| Normal-vs-Female |
1.415800E-03 |
| Male-vs-Female |
6.931600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.924200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.341870E-03 |
| Normal-vs-Age(61-80Yrs) |
4.03009999999648E-05 |
| Normal-vs-Age(81-100Yrs) |
1.68481999999193E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.505600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.562600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.378240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.549600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.397590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.171600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.48560002872267E-09 |
| Normal-vs-Grade 2 |
7.58400000000492E-05 |
| Normal-vs-Grade 3 |
7.87690000000341E-05 |
| Normal-vs-Grade 4 |
1.264370E-01 |
| Grade 1-vs-Grade 2 |
5.139000E-03 |
| Grade 1-vs-Grade 3 |
3.043900E-04 |
| Grade 1-vs-Grade 4 |
7.64109999999985E-05 |
| Grade 2-vs-Grade 3 |
6.394000E-01 |
| Grade 2-vs-Grade 4 |
2.992100E-02 |
| Grade 3-vs-Grade 4 |
4.703800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.78999999999441E-05 |
| Normal-vs-ccB subtype |
5.848500E-04 |
| ccA subtype-vs-ccB subtype |
1.839790E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.81900999999263E-05 |
| Normal-vs-N1 |
8.798200E-01 |
| N0-vs-N1 |
2.181900E-02 |
|
|
